
NYSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$8.68
−$0.67 · -7.17%
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Previous close
$8.68
−$0.67 · -7.17%
Regular session · ET · Market data may be delayed.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $8.68
52-week range
Current $8.68
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
61
Undervalued
Sentiment
53
Mixed
Risk
67
High Risk
Momentum
57
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $8.68
52-week range
Current $8.68
| Metric (USD) | FY2025 |
|---|---|
| Revenue | 1.18B USD |
| Cost of goods sold | 470.01M USD |
| Gross profit | 711.17M USD |
| Selling, general, and administrative | 445.21M USD |
| Operating expenses | 562.85M USD |
| Interest income | 14.52M USD |
| Interest expense | 63.45M USD |
| Depreciation and amortization | 173.4M USD |
| Operating income | 148.32M USD |
| Net income | −116.38M USD |
Company facts updated Nov 22, 2026.
Funds reporting this stock among their holdings, ordered by reported position size.
AdvisorShares Pure US Cannabis ETFMSOS216.8M38.89%648.87M USD0.75%$3.14-7.10%
Vanguard Extended Market ETFVXF19.91M0.02%30.2B USD0.05%$211.44-3.21%
Vanguard Morningstar Total Stock Market ETFVTI11.31M0.00%689.3B USD0.03%$340.02-3.52%
Schwab U.S. Small-Cap ETFSCHA8.3M0.04%20.45B USD0.03%$30.51-2.83%
Amplify Seymour Cannabis ETFCNBS8.27M15.99%49.9M USD1.09%$18.26-6.36%
First Trust Small Cap Growth AlphaDEX FundFYC5.63M0.45%1.26B USD0.70%$103.45-3.18%
AdvisorShares Pure Cannabis ETFYOLO3.96M16.23%24.38M USD1.45%$2.11-4.74%
First Trust Small Cap Core AlphaDEX FundFYX2.7M0.21%1.29B USD0.58%$129.16-2.03%
AdvisorShares Pure US Cannabis ETFMSOS
Vanguard Extended Market ETFVXF
Vanguard Morningstar Total Stock Market ETFVTI
Schwab U.S. Small-Cap ETFSCHA
Amplify Seymour Cannabis ETFCNBS
First Trust Small Cap Growth AlphaDEX FundFYC
AdvisorShares Pure Cannabis ETFYOLO
First Trust Small Cap Core AlphaDEX FundFYXAI-generated and delayed market data for informational and educational purposes only. Not investment advice.